Hyperion Defi (HYPD) Free Cash Flow (2017 - 2026)
Hyperion Defi (HYPD) posted quarterly Free Cash Flow of -$4.2 million for Q1 2026, up 5.54% year-over-year from -$4.0 million in Q1 2025, and down 3.11% quarter-over-quarter from -$4.1 million in Q4 2025.
Hyperion Defi (HYPD) Free Cash Flow (2017 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Free Cash Flow for 10 consecutive years, with -$4.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow rose 5.54% year-over-year to -$4.2 million; the TTM figure through Mar 2026 stood at -$14.5 million (up 41.19% YoY), while the FY2025 annual figure was -$14.8 million, up 51.19% from the prior year.
- Free Cash Flow fell to -$4.2 million in Q1 2026 per HYPD's latest filing, from -$4.1 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$2.8 million in Q3 2025 and bottomed at -$10.0 million in Q1 2024.
- Historically, Free Cash Flow has averaged -$6.0 million across 5 years, with a median of -$5.9 million in 2024.
- Annual changes were most pronounced in 2022 — Free Cash Flow plunged 694.06% — and 2025, when it soared 58.07%.
- Hyperion Defi's Free Cash Flow stood at -$5.4 million in 2022, then decreased by 19.08% to -$6.5 million in 2023, then advanced by 5.84% to -$6.1 million in 2024, then jumped by 33.17% to -$4.1 million in 2025, then slipped by 3.11% to -$4.2 million in 2026.
- Business Quant data shows HYPD's Free Cash Flow at -$4.2 million in Q1 2026, -$4.1 million in Q4 2025, and -$2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Hyperion Defi | 44.93 Mn | 35.29 Mn | 357,693.00 | -10.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.90 Mn |
| Jun 30, 2026 | -2.90 Mn |
| Mar 31, 2026 | -4.20 Mn |
| Mar 31, 2026 | -4.20 Mn |
| Dec 31, 2025 | -4.07 Mn |
| Dec 31, 2025 | -4.07 Mn |
| Sep 30, 2025 | -2.81 Mn |
| Sep 30, 2025 | -2.81 Mn |
| Jun 30, 2025 | -3.45 Mn |
| Jun 30, 2025 | -3.45 Mn |
| Mar 31, 2025 | -4.44 Mn |
| Mar 31, 2025 | -4.44 Mn |
| Dec 31, 2024 | -6.09 Mn |
| Dec 31, 2024 | -6.09 Mn |
| Sep 30, 2024 | -5.95 Mn |
| Sep 30, 2024 | -5.95 Mn |
| Jun 30, 2024 | -8.22 Mn |
| Jun 30, 2024 | -8.22 Mn |
| Mar 31, 2024 | -10.01 Mn |
| Mar 31, 2024 | -10.01 Mn |